Pharmaceuticals

InterAx partners with Lundbeck to identify better pharmaceutical compounds

InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...

More details More details

PARK INNOVAARE welcomes Excelsus Structural Solutions

Excelsus Structural Solutions (Swiss) AG, Villigen, a spin-off company of the Paul Scherrer Institute (PSI), has moved to PARK INNOVAARE’s deliveryLAB....

More details

leadXpro one year in operation: all goals achieved, and even more!

Today, leadXpro AG, one of PARK INNOVAARE’s residents, celebrates its first anniversary and breathtaking development as a company in its first year of...

More details

INNOVATION in PRACTICE 2017: technologies and products in focus

Innovation cannot be planned. But it can be achieved faster and more effectively when the innovation process is being managed properly. For the second...

More details

InterAx Biotech has started a new collaboration

Collaborations speed up innovation. InterAx Biotech AG, a spin-off of the Paul Scherrer Institute (PSI) and ETH Zurich, based at PARK INNOVAARE, and Professor...

More details

Excelsus Structural Solutions (ESS): Collaborates with Improved Pharma LLC

Excelsus Structural Solutions (ESS) is proud to announce a collaboration with Improved Pharma LLC (co-founded by Stephen Byrn, Professor at Purdue University,...

More details

Excelsus invites pharma companies to explore for free the possibilities of synchrotron X-ray powder diffraction

The second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...

More details

A perfect site for biotech and pharma companies!

Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...

More details

Pharmaceutical formulations: Excelsus quantifies amorphous drug forms

Using state-of-the-art synchrotron X-ray powder diffraction at the Paul Scherrer Institute (PSI) and the pair distribution function (PDF) technique, Excelsus...

More details

Electron diffraction opens new possibilities for structure-based drug discovery

Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. The reason why the atomic structure...

More details

The value of the absolute structure

The exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical, agrarian and pharmaceutical research....

More details

Crystallization at its best

The success of many R&D projects in the pharmaceutical, chemical or agro industries depends on the exact and complete knowledge of a sample. To deliver...

More details
Subscribe to Pharmaceuticals